LLY News and Press, Eli Lilly and Company From 05/24/24

2024-05-24 09:17:15 ET Summary Medifast's financial performance is deteriorating rapidly due to the emergence of drug-weight loss competitors. The company reported a significant decline in revenue and earnings in Q1 2023. Medifast is laying off employees and may need to furthe...

2024-05-24 07:06:38 ET More on Novo Nordisk The FTC Cracks Down On Novo Nordisk's Ozempic Novo Nordisk A/S 2024 Q1 - Results - Earnings Call Presentation Novo Nordisk A/S (NVO) Q1 2024 Earnings Call Transcript SA Asks: Is Eli Lilly or Novo Nordisk a better in...

Lilly Announces Details of Presentations at 2024 American Society of Clinical Oncology (ASCO) Annual Meeting PR Newswire INDIANAPOLIS , May 23, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced that data from studies of Verzenio ® (a...

A look at the top 10 most actives in the United States Greenwave Technology Solutions Inc. (GWAV) rose 12.4% to $0.0886 on volume of 1,366,648,994 shares Ascent Solar Technologies Inc (ASTI) rose 63.4% to $0.2147 on volume of 656,794,712 shares Pineapple Energy Inc. (PEGY) rose 61.4% to $...

2024-05-23 14:07:59 ET More on Eli Lilly, Novo Nordisk, etc. Eli Lilly: Great Time To Divest Before It Potentially Crashes Eli Lilly Remains Expensive Here - Minimal Margin Of Safety The FTC Cracks Down On Novo Nordisk's Ozempic FDA reviewers voice concerns o...

2024-05-23 12:36:52 ET Summary Lantheus Holdings, Inc. excels in radiopharmaceuticals, with PYLARIFY's dominance in PSMA PET imaging. The market for radiopharmaceuticals is expanding beyond all expectations by both industry experts and the company's management. Lantheus is act...

2024-05-23 08:05:00 ET There are many stocks that you can invest in for the long haul and effectively forget about. These are businesses with robust financials, strong growth prospects, and a lot of stability for investors. They are what you would consider to be blue chip stocks. ...

2024-05-23 06:45:00 ET Eli Lilly (NYSE: LLY) can't stop grabbing headlines. The pharmaceutical company has made quite a bit of noise over the past few years thanks to notable clinical and regulatory progress. Investors have rewarded the drugmaker accordingly -- Eli Lilly's shares ha...

2024-05-22 20:25:32 ET Summary Jeremy Grantham's 13F portfolio value increased from $22.66B to $27.52B this quarter. The largest five stakes in the portfolio are Microsoft Corporation, Alphabet, Meta Platforms, UnitedHealth, and Apple. GMO's 7-year asset class real return fore...

2024-05-22 13:32:00 ET Summary Australia to ban compounded versions of Novo Nordisk's semaglutide and Eli Lilly's tirzepatide due to safety concerns. Existing home sales dipped 1.89% in April to 4.14 million. All eyes on Nvidia earnings but BofA points to another stock that de...